I get a real sense that momentum with BTM is really building strongly in the UK/Europe (esp DACH region). The fact that this is a paediatric conference bodes well. I would say in general surgeons would normally try new products like BTM on adults first or wait and see results in adults before using in a paed setting, but with recent BBA conference and now this reporting multiple paed cases I think the reins are about to come off and sales are going to gallop away. Fair chance DW might have seen some UK/Europe sales figures!!!
I get a real sense that momentum with BTM is really building...
-
- There are more pages in this discussion • 904 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
0.040(1.57%) |
Mkt cap ! $1.781B | |||
| Open | High | Low | Value | Volume |
| $2.56 | $2.59 | $2.53 | $3.881M | 1.517M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10150 | $2.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 38947 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |